North Carolina is suing Juul for targeting young consumers with its e-cigarette design and marketing campaigns. It is the first state to do so. State Attorney General Josh Stein is planning to argue that Juul did not accurately portray the potency and danger of its products.  (Washington Post)

Johnson & Johnson is planning to launch 10 drugs by 2023, according to CEO Alex Gorsky. The drugmaker is hoping to grow its pharmaceutical business while dealing with the thousands of talc-related lawsuits its consumer products division is facing. Prescription drugs made up half of J&J’s $81.6 billion in 2018 sales. (CNBC)

Novartis could be close to settling a lawsuit alleging that it used kickbacks to doctors to increase prescriptions. The drugmaker could reportly pay nearly $1 billion to close the case. The trial date is set for this Monday in New York City. (STAT)

Sanofi is studying a digital therapy for depression and multiple sclerosis in partnership with Happify Health, which could be a more affordable alternative to developing a drug for treatment. Last year, Novartis and Pear Therapeutics were the first to receive approval from the Food and Drug Administration for a similar therapy to treat substance abuse. (Bloomberg)

Alphabet’s Verily and GV units have been investing in Verve Therapeutics, a startup focused on developing an injectable treatment for cardiovascular disease. Dr. Sek Kathiresan recently joined Verve as CEO. (CNBC)